Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6035)
All Articles published online
|
Publishing Process of This Article
|
May 28, 2014 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Tan YLJ, Chen WN. MicroRNAs as therapeutic strategy for hepatitis B virus-associated hepatocellular carcinoma: Current status and future prospects. World J Gastroenterol 2014; 20(20): 5973-5986 [PMID: 24876720 DOI: 10.3748/wjg.v20.i20.5973] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v20/i20/5973.htm |
| Number | Citing Articles |
| 1 |
Pengyuan Yang, Geoffrey J. Markowitz, Xiao-Fan Wang. The hepatitis B virus-associated tumor microenvironment in hepatocellular carcinoma. National Science Review 2014; 1(3): 396 doi: 10.1093/nsr/nwu038
|
| 2 |
Rania H. Mahmoud, Enas Mamdouh Hefzy, Olfat G. Shaker, Tarek I. Ahmed, Noha K. Abdelghaffar, Essam A. Hassan, Amal A. Ibrahim, Doaa Y. Ali, Mohamed M. Mohamed, Omayma O. Abdelaleem. GAS5 rs2067079 and miR-137 rs1625579 functional SNPs and risk of chronic hepatitis B virus infection among Egyptian patients. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-99345-2
|
| 3 |
Ioannis Anestopoulos, Georgia Persephoni Voulgaridou, Alexandros G. Georgakilas, Rodrigo Franco, Aglaia Pappa, Mihalis I. Panayiotidis. Epigenetic therapy as a novel approach in hepatocellular carcinoma. Pharmacology & Therapeutics 2015; 145: 103 doi: 10.1016/j.pharmthera.2014.09.005
|
| 4 |
Wen-Shu Chen, Liang-Chih Liu, Chia-Jui Yen, Yun-Ju Chen, Jhen-Yu Chen, Chien-Yi Ho, Shu-Hui Liu, Ching-Chow Chen, Wei-Chien Huang. Nuclear IKKα mediates microRNA-7/-103/107/21 inductions to downregulate maspin expression in response to HBx overexpression. Oncotarget 2016; 7(35): 56309 doi: 10.18632/oncotarget.10462
|
| 5 |
Zhao-Shan Niu, Xiao-Jun Niu, Wen-Hong Wang, Jing Zhao. Latest developments in precancerous lesions of hepatocellular carcinoma. World Journal of Gastroenterology 2016; 22(12): 3305-3314 doi: 10.3748/wjg.v22.i12.3305
|
| 6 |
Juan Du, Fuxiang Bai, Peiqing Zhao, Xiaoyan Li, Xueen Li, Lifen Gao, Chunhong Ma, Xiaohong Liang. Hepatitis B core protein promotes liver cancer metastasis through miR-382-5p/DLC-1 axis. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 2018; 1865(1): 1 doi: 10.1016/j.bbamcr.2017.09.020
|
| 7 |
Fatma A. Fathy.Elmougy, Reham A. Mohamed, Mona M. Hassan, Suzan M. Elsheikh, Raghda N. Marzban, Fatma-elzahraa M. Ahmed, Rady E. Elaraby. Study of serum microRNA19a and microRNA223 as potential biomarkers for early diagnosis of hepatitis C virus-related hepatocellular carcinoma. Gene Reports 2019; 15: 100398 doi: 10.1016/j.genrep.2019.100398
|
| 8 |
Yong Gao, Juan Gu, Yueping Wang, Decai Fu, Wensheng Zhang, Guofu Zheng, Xuedong Wang. Hepatitis B virus X protein boosts hepatocellular carcinoma progression by downregulating microRNA-137. Pathology - Research and Practice 2020; 216(6): 152981 doi: 10.1016/j.prp.2020.152981
|
| 9 |
Yu-Cheng Zhang, Zhuo Xu, Tian-Fu Zhang, Ya-Li Wang. Circulating microRNAs as diagnostic and prognostic tools for hepatocellular carcinoma. World Journal of Gastroenterology 2015; 21(34): 9853-9862 doi: 10.3748/wjg.v21.i34.9853
|
| 10 |
Lin Chen, Haitao Guan, Chunyan Gu, Yali Cao, Jianguo Shao, Feng Wang. miR-383 inhibits hepatocellular carcinoma cell proliferation via targeting APRIL. Tumor Biology 2016; 37(2): 2497 doi: 10.1007/s13277-015-4071-1
|
| 11 |
Ye Zhen, Zhao Xinghui, Wu Chao, Zhao Yi, Chen Jinwen, Gao Ruifang, Zhang Chao, Zhao Min, Guo Chunlei, Fang Yan, Du Lingfang, Shen Long, Shen Wenzhi, Luo Xiaohe, Xiang Rong. Several microRNAs could predict survival in patients with hepatitis B-related liver cancer. Scientific Reports 2017; 7(1) doi: 10.1038/srep45195
|